151 related articles for article (PubMed ID: 29475961)
1. Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments.
Cho SY; Sung CO; Chae J; Lee J; Na D; Kang W; Kang J; Min S; Lee A; Kwak E; Kim J; Choi B; Kim H; Chuang JH; Pak HK; Park CS; Park S; Ko YH; Lee D; Roh J; Cho MS; Park S; Ju YS; Suh YS; Kong SH; Lee HJ; Keck J; Banchereau J; Liu ET; Kim WH; Park H; Yang HK; Kim JI; Lee C
Blood; 2018 Apr; 131(17):1931-1941. PubMed ID: 29475961
[TBL] [Abstract][Full Text] [Related]
2. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
[TBL] [Abstract][Full Text] [Related]
3. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
[TBL] [Abstract][Full Text] [Related]
4. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
[TBL] [Abstract][Full Text] [Related]
5. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
6. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
7. EBV-associated lymphoepithelioma-like gastric carcinoma in a patient with HIV.
Kim J; Kim KM; Noh JH; Park CK
Pathology; 2009; 41(6):593-5. PubMed ID: 19900113
[No Abstract] [Full Text] [Related]
8. Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.
Mukohyama J; Iwakiri D; Zen Y; Mukohara T; Minami H; Kakeji Y; Shimono Y
Oncotarget; 2016 Aug; 7(31):50150-50160. PubMed ID: 27367028
[TBL] [Abstract][Full Text] [Related]
9. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
[TBL] [Abstract][Full Text] [Related]
10. EBV-positive mucocutaneous ulcer within colonic diverticulitis mimicking diffuse large B cell lymphoma.
Zanelli M; Zizzo M; Foroni M; De Marco L; Martino G; Ascani S
Ann Hematol; 2019 Jul; 98(7):1795-1797. PubMed ID: 31093707
[No Abstract] [Full Text] [Related]
11. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL.
Nagel S; Uphoff CC; Dirks WG; Pommerenke C; Meyer C; Drexler HG
PLoS One; 2019; 14(5):e0216898. PubMed ID: 31141539
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
14. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
15. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
16. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway.
Fukagawa Y; Nishikawa J; Kuramitsu Y; Iwakiri D; Takada K; Imai S; Satake M; Okamoto T; Fujimoto M; Okita K; Nakamura K; Sakaida I
Electrophoresis; 2008 Aug; 29(15):3192-200. PubMed ID: 18604870
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]